These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1635566)

  • 21. Phase II, randomized, controlled, double-blinded trial of weekly elesclomol plus paclitaxel versus paclitaxel alone for stage IV metastatic melanoma.
    O'Day S; Gonzalez R; Lawson D; Weber R; Hutchins L; Anderson C; Haddad J; Kong S; Williams A; Jacobson E
    J Clin Oncol; 2009 Nov; 27(32):5452-8. PubMed ID: 19826135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Combination of fotemustine-dacarbazine and interferon alpha in the treatment of metastatic malignant melanoma].
    Célérier P; Dreno B; Bureau B; Litoux P
    Ann Dermatol Venereol; 1993; 120(6-7):437-40. PubMed ID: 8279787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term survival in metastatic melanoma patients treated with sequential biochemotherapy: report of a Phase II study.
    Neri B; Vannozzi L; Fulignati C; Pantaleo P; Pantalone D; Paoletti C; Perfetto F; Turrini M; Mazzanti R
    Cancer Invest; 2006; 24(5):474-8. PubMed ID: 16939954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: an Eastern Cooperative Oncology Group study.
    Falkson CI; Ibrahim J; Kirkwood JM; Coates AS; Atkins MB; Blum RH
    J Clin Oncol; 1998 May; 16(5):1743-51. PubMed ID: 9586887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase II study of chemoneuroimmunotherapy with platinum, subcutaneous low-dose interleukin-2 and the pineal neurohormone melatonin (P.I.M.) as a second-line therapy in metastatic melanoma patients progressing on dacarbazine plus interferon-alpha.
    Lissoni P; Vaghi M; Ardizzoia A; Malugani F; Fumagalli E; Bordin V; Fumagalli L; Bordoni A; Mengo S; Gardani GS; Tancini G
    In Vivo; 2002; 16(2):93-6. PubMed ID: 12073777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG).
    Hauschild A; Garbe C; Stolz W; Ellwanger U; Seiter S; Dummer R; Ugurel S; Sebastian G; Nashan D; Linse R; Achtelik W; Mohr P; Kaufmann R; Fey M; Ulrich J; Tilgen W
    Br J Cancer; 2001 Apr; 84(8):1036-42. PubMed ID: 11308250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen, or vindesine plus tamoxifen: a prospective randomized study.
    Cocconi G; Passalacqua R; Foladore S; Carlini P; Acito L; Maiello E; Marchi M; Gebbia V; Di Sarra S; Beretta M; Bacchi M
    Melanoma Res; 2003 Feb; 13(1):73-9. PubMed ID: 12569288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma.
    Robert C; Thomas L; Bondarenko I; O'Day S; Weber J; Garbe C; Lebbe C; Baurain JF; Testori A; Grob JJ; Davidson N; Richards J; Maio M; Hauschild A; Miller WH; Gascon P; Lotem M; Harmankaya K; Ibrahim R; Francis S; Chen TT; Humphrey R; Hoos A; Wolchok JD
    N Engl J Med; 2011 Jun; 364(26):2517-26. PubMed ID: 21639810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The addition of tamoxifen to dacarbazine and cisplatin in metastatic malignant melanoma. A phase II trial of the Southwest Oncology Group, (SWOG-8921).
    Flaherty LE; Liu PY; Mitchell MS; Fletcher WS; Walker MJ; Goodwin JW; Stephens RL; Sondak VK
    Am J Clin Oncol; 1996 Apr; 19(2):108-13. PubMed ID: 8610631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tamoxifen and chemotherapy for refractory metastatic malignant melanoma.
    McKeage MJ; Lorentzos A; Gore ME
    N Engl J Med; 1993 Jan; 328(2):140-1. PubMed ID: 8416433
    [No Abstract]   [Full Text] [Related]  

  • 31. Dacarbazine, cisplatin and carmustine, with or without tamoxifen, for metastatic melanoma: 5-year follow-up.
    Lattanzi SC; Tosteson T; Chertoff J; Maurer LH; O'Donnell J; LeMarbre PJ; Mott L; DelPrete SA; Forcier RJ; Ernstoff MS
    Melanoma Res; 1995 Oct; 5(5):365-9. PubMed ID: 8541728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dacarbazine-based chemotherapy as first-line treatment in noncutaneous metastatic melanoma: multicenter, retrospective analysis in Asia.
    Yi JH; Yi SY; Lee HR; Lee SI; Lim DH; Kim JH; Park KW; Lee J
    Melanoma Res; 2011 Jun; 21(3):223-7. PubMed ID: 21471822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disseminated melanoma--is there a new standard therapy?
    Guerry D; Schuchter LM
    N Engl J Med; 1992 Aug; 327(8):560-1. PubMed ID: 1635572
    [No Abstract]   [Full Text] [Related]  

  • 34. Health-related quality of life among patients with metastatic melanoma: results from an international phase 2 multicenter study.
    Robinson DW; Cormier JN; Zhao N; Uhlar CM; Revicki DA; Cella D
    Melanoma Res; 2012 Feb; 22(1):54-62. PubMed ID: 22027908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of stage IV malignant melanoma with dacarbazine, carmustine, cisplatin, and tamoxifen regimens: a University of South Florida and H. Lee Moffitt Melanoma Center Study.
    Saba HI; Cruse CW; Wells KE; Klein CJ; Reintgen DS
    Ann Plast Surg; 1992 Jan; 28(1):65-9. PubMed ID: 1642409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three-drug combination of cisplatin, dacarbazine, and tamoxifen in metastatic malignant melanoma.
    Chmielowska E; Potemski P; Pluzańska A
    J Clin Oncol; 1995 Aug; 13(8):2146-7. PubMed ID: 7636562
    [No Abstract]   [Full Text] [Related]  

  • 37. High-dose cisplatin with dacarbazine and tamoxifen in the treatment of metastatic melanoma.
    Buzaid AC; Murren JR; Durivage HJ
    Cancer; 1991 Sep; 68(6):1238-41. PubMed ID: 1873775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant chemotherapy in malignant melanoma using dacarbazine, carmustine, cisplatin, and tamoxifen: a University of South Florida and H. Lee Moffitt Melanoma Center Study.
    Saba HI; Cruse CW; Wells KE; Klein CJ; Reintgen DS
    Ann Plast Surg; 1992 Jan; 28(1):60-4. PubMed ID: 1642408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination chemotherapy of metastatic melanoma.
    Berd D; Mastrangelo MJ
    J Clin Oncol; 1995 Mar; 13(3):796-7. PubMed ID: 7884439
    [No Abstract]   [Full Text] [Related]  

  • 40. [Combined treatment with dacarbazine, nimustine, cisplatin, and tamoxifen plus interferon-beta in a patient with advanced anorectal malignant melanoma].
    Kawano N; Tashiro M; Taguchi M; Kihara Y; Yoshikawa I; Syukuwa K; Yamasaki M; Kume K; Otsuki M
    Nihon Shokakibyo Gakkai Zasshi; 2008 Nov; 105(11):1627-33. PubMed ID: 18987448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.